- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
1 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €340.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.26
7D
1.4%
1Y
-31.1%
MPH Health Care
Market Cap: €100.6m
An investment company, engages in the healthcare business in Germany.
New
93M1
€23.90
7D
0.8%
1Y
43.1%
Novogenia
Market Cap: €80.4m
Manufactures and sells personalized health products in global markets.
7V0
€6.70
7D
0%
1Y
-8.2%
Cantourage Group
Market Cap: €70.3m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.64
7D
2.2%
1Y
37.9%